AAAAAA

   
Results: 1-8 |
Results: 8
Impact of number of nodes retrieved on outcome in patients with rectal cancer
Authors: Tepper, JE O'Connell, MJ Niedzwiecki, D Hollis, D Compton, C Benson, AB Cummings, B Gunderson, L Macdonald, JS Mayer, RJ
Citation: Je. Tepper et al., Impact of number of nodes retrieved on outcome in patients with rectal cancer, J CL ONCOL, 19(1), 2001, pp. 157-163
Recommendation for caution with irinotecan, fluorouracil, and leucovorin for colorectal cancer.
Authors: Sargent, DJ Niedzwiecki, D O'Connell, MJ Schilsky, RL
Citation: Dj. Sargent et al., Recommendation for caution with irinotecan, fluorouracil, and leucovorin for colorectal cancer., N ENG J MED, 345(2), 2001, pp. 144-145
Nicotinamide adenine dinucleotide (NAD) and its metabolites inhibit T lymphocyte proliferation: Role of cell surface NAD glycohydrolase and pyrophosphatase activities
Authors: Bortell, R Moss, J McKenna, RC Rigby, MR Niedzwiecki, D Stevens, LA Patton, WA Mordes, JP Greiner, DL Rossini, AA
Citation: R. Bortell et al., Nicotinamide adenine dinucleotide (NAD) and its metabolites inhibit T lymphocyte proliferation: Role of cell surface NAD glycohydrolase and pyrophosphatase activities, J IMMUNOL, 167(4), 2001, pp. 2049-2059
Phase II study of oral eniluracil, 5-fluorouracil, and leucovorin in patients with advanced colorectal carcinoma
Authors: Meropol, NJ Niedzwiecki, D Hollis, D Schilsky, RL Mayer, RJ
Citation: Nj. Meropol et al., Phase II study of oral eniluracil, 5-fluorouracil, and leucovorin in patients with advanced colorectal carcinoma, CANCER, 91(7), 2001, pp. 1256-1263
Phase II study of infusional chemotherapy with doxorubicin, vincristine and etoposide plus cyclophosphamide and prednisone (I-CHOPE) in resistant diffuse aggressive non-Hodgkin's lymphoma: CALGB 9255
Authors: Lichtman, SM Niedzwiecki, D Barcos, M Carlisle, TL Cooper, MR Johnson, JL Peterson, BA
Citation: Sm. Lichtman et al., Phase II study of infusional chemotherapy with doxorubicin, vincristine and etoposide plus cyclophosphamide and prednisone (I-CHOPE) in resistant diffuse aggressive non-Hodgkin's lymphoma: CALGB 9255, ANN ONCOL, 11(9), 2000, pp. 1141-1146
Preoperative mobilization of circulating dendritic cells by Flt3 ligand administration to patients with metastatic colon cancer
Authors: Morse, MA Nair, S Fernandez-Casal, M Deng, YP St Peter, M Williams, R Hobeika, A Mosca, P Clay, T Cumming, RI Fisher, E Clavien, P Proia, AD Niedzwiecki, D Caron, D Lyerly, HK
Citation: Ma. Morse et al., Preoperative mobilization of circulating dendritic cells by Flt3 ligand administration to patients with metastatic colon cancer, J CL ONCOL, 18(23), 2000, pp. 3883-3893
Safety of nifedipine in patients with hypertension: a meta-analysis (vol 30, pg 7, 1995)
Authors: Stason, WB Schmid, CH Niedzwiecki, D Whiting, GW Caubet, JF Luo, D Ross, SD Chalmers, TC
Citation: Wb. Stason et al., Safety of nifedipine in patients with hypertension: a meta-analysis (vol 30, pg 7, 1995), HYPERTENSIO, 34(3), 1999, pp. 531-531
Safety of nifedipine in angina pectoris - A meta-analysis
Authors: Stason, WB Schmid, CH Niedzwiecki, D Whiting, GW Caubet, JF Cory, D Luo, D Ross, SD Chalmers, TC
Citation: Wb. Stason et al., Safety of nifedipine in angina pectoris - A meta-analysis, HYPERTENSIO, 33(1), 1999, pp. 24-31
Risultati: 1-8 |